Clinical Trials Browser

Phase 1/2 × Alzheimer Disease × CNS × Clear all

NCT04971733 2025-06-10

A Study to Assess Safety and Target Engagement of E2814 in Participants With Mild to Moderate Cognitive Impairment Due to Dominantly Inherited Alzheimer's Disease

Phase 1/2 Completed

8 enrolled 21 charts

Alzheimer Disease, Central Nervous System Diseases, Lymphoma, Follicular